4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Corcept Therapeutics Incorporated (CORT) operates in the Biotechnology industry and is headquartered in Redwood City, United States with about 730 employees. Its market capitalization is roughly $10 billion. In the fiscal year ended 2025-12-31, CORT reported $761M in revenue and $100M in net income.
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
Interactive charts & full statements → Open the CORT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $761M | $675M | $482M | $402M | — |
| Gross Profit | $748M | $664M | $476M | $396M | — |
| Operating Income (EBIT) | $45M | $137M | $107M | $113M | — |
| Net Income | $100M | $141M | $106M | $101M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $165M | $202M | $208M | $194M | $157M | — |
| Gross Profit | $162M | $200M | $203M | $191M | $155M | — |
| Operating Income (EBIT) | ($50M) | $4M | $10M | $27M | $3M | — |
| Net Income | ($32M) | $24M | $20M | $35M | $20M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $837M | $841M | $622M | $583M | — |
| Total Liabilities | $189M | $161M | $115M | $82M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CORT viewer.
About TickerBase · Data methodology & sources